Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM9PSZ1)

Drug Name
BBP-812 Drug Info
Indication
Disease Entry ICD 11 Status REF
Canavan disease 5C50.E1 Phase 1/2 [1]
Cross-matching ID
TTD Drug ID
DM9PSZ1

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Aspartoacylase (ASPA) TT6TLZP ACY2_HUMAN Not Available [2]

References

1 ClinicalTrials.gov (NCT04998396) A Phase 1/2 Open-Label Study of the Safety and Clinical Activity of Gene Therapy for Canavan Disease Through Administration of an Adeno-Associated Virus (AAV) Serotype 9-Based Recombinant Vector Encoding the Human ASPA Gene. U.S.National Institutes of Health.
2 Clinical pipeline report, company report or official report of Adrenas Therapeutics